Who has invested in Exagen Group?

Octopus Energy are named among the investors backing Exagen Group.

Exagen Group Funding: $110M Raised, Seed (2022)

Exagen Group funding overview

Exagen Group is based in London, United Kingdom. Exagen Group has raised $110M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Seed announced in August 2022. The round record for Exagen Group runs through 2022; nothing later has been disclosed. Investors on record include Octopus Energy.

Exagen Group at a glance

Total raised: $110M
Latest round: Seed
Latest round date: August 2022
Headquarters: London, United Kingdom
Notable investors: Octopus Energy

Frequently asked about Exagen Group funding

How much has Exagen Group raised?: Exagen Group has raised $110M in total disclosed funding across the rounds on record.
Who has invested in Exagen Group?: Octopus Energy are named among the investors backing Exagen Group.
What was the latest Exagen Group funding round?: The most recent disclosed round is a Seed, announced in August 2022.
Where is Exagen Group based?: Exagen Group is based in London, United Kingdom.
When did Exagen Group last raise?: The last disclosed Exagen Group round closed in August 2022 at Seed.

Exagen Group totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in London below to benchmark round size and investor mix.

Exagen Group Funding: $110M Raised, Seed (2022)

Exagen Group funding overview

Exagen Group at a glance

Frequently asked about Exagen Group funding

Companies related to Exagen Group (19)

Browse related funding lists (5)